LNC Therapeutics' Series C Round

LNC Therapeutics raised a round of funding on September 28, 2017. Investors include Seventure Partners.

LNC Therapeutics, fka Nutrition Laboratories & Cardio, develops gut microbiota directed drugs to tackle obesity and its associated cardiometabolic diseases.…

Articles about LNC Therapeutics' Series C Round: